Genome-wide association study of cognitive function in diverse Hispanics/Latinos: results from the Hispanic Community Health Study/Study of Latinos.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
22 07 2020
Historique:
received: 09 06 2020
accepted: 03 07 2020
revised: 19 06 2020
entrez: 24 7 2020
pubmed: 24 7 2020
medline: 22 6 2021
Statut: epublish

Résumé

Cognitive function such as reasoning, attention, memory, and language is strongly correlated with brain aging. Compared to non-Hispanic whites, Hispanics/Latinos have a higher risk of cognitive impairment and dementia. The genetic determinants of cognitive function have not been widely explored in this diverse and admixed population. We conducted a genome-wide association analysis of cognitive function in up to 7600 middle aged and older Hispanics/Latinos (mean = 55 years) from the Hispanic Community Health Study / Study of Latinos (HCHS/SOL). Four cognitive measures were examined: the Brief Spanish English Verbal Learning Test (B-SEVLT), the Word Fluency Test (WFT), the Digit Symbol Substitution Test (DSST), the Six-Item Screener (SIS). Four novel loci were identified: one for B-SEVLT at 4p14, two for WFT at 3p14.1 and 6p21.32, and one for DSST at 10p13. These loci implicate genes highly expressed in brain and previously connected to neurological diseases (UBE2K, FRMD4B, the HLA gene complex). By applying tissue-specific gene expression prediction models to our genotype data, additional genes highly expressed in brain showed suggestive associations with cognitive measures possibly indicating novel biological mechanisms, including IFT122 in the hippocampus for SIS, SNX31 in the basal ganglia for B-SEVLT, RPS6KB2 in the frontal cortex for WFT, and CSPG5 in the hypothalamus for DSST. These findings provide new information about the genetic determinants of cognitive function in this unique population. In addition, we derived a measure of general cognitive function based on these cognitive tests and generated genome-wide association summary results, providing a resource to the research community for comparison, replication, and meta-analysis in future genetic studies in Hispanics/Latinos.

Identifiants

pubmed: 32699239
doi: 10.1038/s41398-020-00930-2
pii: 10.1038/s41398-020-00930-2
pmc: PMC7376098
doi:

Substances chimiques

UBE2K protein, human EC 2.3.2.23
Ubiquitin-Conjugating Enzymes EC 2.3.2.23

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

245

Subventions

Organisme : U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)
ID : AG048642
Pays : International
Organisme : U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)
ID : AG052409
Pays : International

Références

La Rue, A. & Jarvik, L. F. Cognitive function and prediction of dementia in old age. Int J. Aging Hum. Dev. 25, 79–89 (1987).
pubmed: 3436685
Cervilla, J., Prince, M., Joels, S., Lovestone, S. & Mann, A. Premorbid cognitive testing predicts the onset of dementia and Alzheimer’s disease better than and independently of APOE genotype. J. Neurol. Neurosurg. Psychiatry 75, 1100–1106 (2004).
pubmed: 15258208 pmcid: 1739178
Dickerson, B. C., Sperling, R. A., Hyman, B. T., Albert, M. S. & Blacker, D. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Arch. Gen. Psychiatry 64, 1443–1450 (2007).
pubmed: 18056553 pmcid: 2581771
Rajan, K. B., Wilson, R. S., Weuve, J., Barnes, L. L. & Evans, D. A. Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia. Neurology 85, 898–904 (2015).
pubmed: 26109713 pmcid: 4560057
McClearn, G. E. et al. Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science 276, 1560–1563 (1997).
pubmed: 9171059
McGue, M. & Christensen, K. The heritability of cognitive functioning in very old adults: evidence from Danish twins aged 75 years and older. Psychol. Aging 16, 272–280 (2001).
pubmed: 11405315
McGue, M. & Christensen, K. The heritability of level and rate-of-change in cognitive functioning in Danish twins aged 70 years and older. Exp. Aging Res. 28, 435–451 (2002).
pubmed: 12227922
Giubilei, F. et al. Heritability of neurocognitive functioning in the elderly: evidence from an Italian twin study. Age Ageing 37, 640–646 (2008).
pubmed: 18641001
Davies, G. et al. Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53949). Mol. Psychiatry 20, 183–192 (2015).
pubmed: 25644384 pmcid: 25644384
Debette, S. et al. Genome-wide studies of verbal declarative memory in nondemented older people: the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium. Biol. Psychiatry 77, 749–763 (2015).
pubmed: 25648963
Ibrahim-Verbaas, C. A. et al. GWAS for executive function and processing speed suggests involvement of the CADM2 gene. Mol. Psychiatry 21, 189–197 (2016).
pubmed: 25869804
Davies, G. et al. Genome-wide association study of cognitive functions and educational attainment in UK Biobank (N=112 151). Mol. Psychiatry 21, 758–767 (2016).
pubmed: 27046643 pmcid: 4879186
Trampush, J. W. et al. GWAS meta-analysis reveals novel loci and genetic correlates for general cognitive function: a report from the COGENT consortium. Mol. Psychiatry 22, 336–345 (2017).
pubmed: 5322272 pmcid: 5322272
Davies, G. et al. Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. Nat. Commun. 9, 2098 (2018).
pubmed: 29844566 pmcid: 29844566
US Census Bureau. Vintage 2017 Population Estimates. 2017.
In: Anderson N. B., Bulatao R. A., Cohen B. (eds). Critical Perspectives on Racial and Ethnic Differences in Health in Late Life. Washington (DC), 2004.
Gonzalez, H. M. et al. Neurocognitive function among middle-aged and older Hispanic/Latinos: results from the Hispanic Community Health Study/Study of Latinos. Arch. Clin. Neuropsychol. 30, 68–77 (2015).
pubmed: 25451561
Conomos, M. P. et al. Genetic Diversity and Association Studies in US Hispanic/Latino Populations: Applications in the Hispanic Community Health Study/Study of Latinos. Am. J. Hum. Genet. 98, 165–184 (2016).
pubmed: 26748518 pmcid: 4716704
Lee, J. H. et al. Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Arch. Neurol. 68, 320–328 (2011).
pubmed: 21059989
Ghani, M. et al. Genome-wide survey of large rare copy number variants in Alzheimer’s disease among Caribbean hispanics. G3 (Bethesda) 2, 71–78 (2012).
Sorlie, P. D. et al. Design and implementation of the Hispanic Community Health Study/Study of Latinos. Ann. Epidemiol. 20, 629–641 (2010).
pubmed: 20609343 pmcid: 2904957
Lavange, L. M. et al. Sample design and cohort selection in the Hispanic Community Health Study/Study of Latinos. Ann. Epidemiol. 20, 642–649 (2010).
pubmed: 20609344 pmcid: 2921622
Nelson, S. C. et al. Improved imputation accuracy in Hispanic/Latino populations with larger and more diverse reference panels: applications in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Hum. Mol. Genet. 25, 3245–3254 (2016).
pubmed: 27346520 pmcid: 5179925
Laurie, C. C. et al. Quality control and quality assurance in genotypic data for genome-wide association studies. Genet Epidemiol. 34, 591–602 (2010).
pubmed: 20718045 pmcid: 3061487
Chen, H. et al. Control for population structure and relatedness for binary traits in genetic association studies via logistic mixed models. Am. J. Hum. Genet 98, 653–666 (2016).
pubmed: 27018471 pmcid: 4833218
Gogarten, S. M. et al. Genetic association testing using the GENESIS R/Bioconductor package. Bioinformatics 35, 5346–5348 (2019).
pubmed: 31329242
Zhang, Q. S., Browning, B. L. & Browning, S. R. ASAFE: ancestry-specific allele frequency estimation. Bioinformatics 32, 2227–2229 (2016).
pubmed: 27153656 pmcid: 4937201
The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am. J. Epidemiol. 129, 687–702 (1989).
Friedman, G. D. et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J. Clin. Epidemiol. 41, 1105–1116 (1988).
pubmed: 3204420
Sonnega, A. et al. Cohort Profile: the Health and Retirement Study (HRS). Int J. Epidemiol. 43, 576–585 (2014).
pubmed: 24671021 pmcid: 3997380
Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet 88, 76–82 (2011).
pubmed: 21167468 pmcid: 3014363
Lee, S. H., Yang, J., Goddard, M. E., Visscher, P. M. & Wray, N. R. Estimation of pleiotropy between complex diseases using single-nucleotide polymorphism-derived genomic relationships and restricted maximum likelihood. Bioinformatics 28, 2540–2542 (2012).
pubmed: 22843982 pmcid: 22843982
Li, Y. & Kellis, M. Joint Bayesian inference of risk variants and tissue-specific epigenomic enrichments across multiple complex human diseases. Nucleic Acids Res. 44, e144 (2016).
pubmed: 27407109 pmcid: 5062982
Watanabe, K., Taskesen, E., van Bochoven, A. & Posthuma, D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 8, 1826 (2017).
pubmed: 29184056 pmcid: 29184056
Gamazon, E. R. et al. A gene-based association method for mapping traits using reference transcriptome data. Nat. Genet. 47, 1091–1098 (2015).
pubmed: 4552594 pmcid: 4552594
Bakshi, A. et al. Fast set-based association analysis using summary data from GWAS identifies novel gene loci for human complex traits. Sci. Rep. 6, 32894 (2016).
pubmed: 27604177 pmcid: 5015118
Pers, T. H. et al. Biological interpretation of genome-wide association studies using predicted gene functions. Nat. Commun. 6, 5890 (2015).
pubmed: 25597830 pmcid: 4420238
Euesden, J., Lewis, C. M. & O’Reilly, P. F. PRSice: Polygenic Risk Score software. Bioinformatics 31, 1466–1468 (2015).
Lee, J. J. et al. Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nat. Genet. 50, 1112–1121 (2018).
pubmed: 30038396 pmcid: 30038396
Wray, N. R. et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat. Genet. 50, 668–681 (2018).
pubmed: 29700475 pmcid: 29700475
Turley, P. et al. Multi-trait analysis of genome-wide association summary statistics using MTAG. Nat. Genet. 50, 229–237 (2018).
pubmed: 29292387 pmcid: 5805593
Bansal, V. et al. Genome-wide association study results for educational attainment aid in identifying genetic heterogeneity of schizophrenia. Nat. Commun. 9, 3078 (2018).
pubmed: 30082721 pmcid: 6079028
Lambert, J. C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat. Genet. 45, 1452–1458 (2013).
pubmed: 3896259 pmcid: 3896259
Verhaaren, B. F. et al. Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRI. Circ. Cardiovasc. Genet. 8, 398–409 (2015).
pubmed: 25663218 pmcid: 4427240
Bis, J. C. et al. Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat. Genet. 44, 545–551 (2012).
pubmed: 22504421 pmcid: 3427729
Grinde, K. E. et al. Generalizing polygenic risk scores from Europeans to Hispanics/Latinos. Genet. Epidemiol. 43, 50–62 (2019).
pubmed: 30368908
Duncan, L. et al. Analysis of polygenic risk score usage and performance in diverse human populations. Nat. Commun. 10, 3328 (2019).
pubmed: 31346163 pmcid: 6658471
Morales, J. et al. A standardized framework for representation of ancestry data in genomics studies, with application to the NHGRI-EBI GWAS Catalog. Genome Biol. 19, 21 (2018).
pubmed: 29448949 pmcid: 5815218
Sirugo, G., Williams, S. M. & Tishkoff, S. A. The missing diversity in human genetic studies. Cell 177, 26–31 (2019).
pubmed: 30901543 pmcid: 7380073
Wojcik, G. L. et al. Genetic analyses of diverse populations improves discovery for complex traits. Nature 570, 514–518 (2019).
pubmed: 31217584 pmcid: 6785182
Guan, R. et al. rbm47, a novel RNA binding protein, regulates zebrafish head development. Dev. Dyn. 242, 1395–1404 (2013).
pubmed: 24038582
Surendran, P. et al. Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension. Nat. Genet. 48, 1151–1161 (2016).
pubmed: 27618447 pmcid: 5056636
Gasecki, D., Kwarciany, M., Nyka, W. & Narkiewicz, K. Hypertension, brain damage and cognitive decline. Curr. Hypertens. Rep. 15, 547–558 (2013).
pubmed: 24146223 pmcid: 3838597
Song, S. et al. E2-25K/Hip-2 regulates caspase-12 in ER stress-mediated Abeta neurotoxicity. J. Cell Biol. 182, 675–684 (2008).
pubmed: 18710920 pmcid: 2518707
de Pril, R., Fischer, D. F., Roos, R. A. & van Leeuwen, F. W. Ubiquitin-conjugating enzyme E2-25K increases aggregate formation and cell death in polyglutamine diseases. Mol. Cell Neurosci. 34, 10–19 (2007).
pubmed: 17092742
Filatova, E. V. et al. Expression analysis of genes of ubiquitin-proteasome protein degradation system in MPTP-induced mice models of early stages of Parkinson’s disease. Dokl. Biochem. Biophys. 456, 116–118 (2014).
pubmed: 24993970
Song, S. & Jung, Y. K. Alzheimer’s disease meets the ubiquitin-proteasome system. Trends Mol. Med 10, 565–570 (2004).
pubmed: 15519283
Meiklejohn, H. et al. Blood and brain protein levels of ubiquitin-conjugating enzyme E2K (UBE2K) are elevated in individuals with schizophrenia. J. Psychiatr. Res. 113, 51–57 (2019).
pubmed: 30901725
Tramutola, A., Di Domenico, F., Barone, E., Perluigi, M. & Butterfield, D. A. It is all about (U)biquitin: role of altered ubiquitin-proteasome system and UCHL1 in Alzheimer disease. Oxid. Med Cell Longev. 2016, 2756068 (2016).
pubmed: 26881020 pmcid: 4736377
Balan, S. et al. 22q11.2 deletion carriers and schizophrenia-associated novel variants. Br. J. Psychiatry 204, 398–399 (2014).
pubmed: 24482440
Deming, Y. et al. A potential endophenotype for Alzheimer’s disease: cerebrospinal fluid clusterin. Neurobiol. Aging 37, 208 e201–208 e209 (2016).
Hu, H. et al. Genome-wide association study identified ATP6V1H locus influencing cerebrospinal fluid BACE activity. BMC Med. Genet. 19, 75 (2018).
pubmed: 29751835 pmcid: 5948839
Humphries, C. E. et al. Integrated whole transcriptome and DNA methylation analysis identifies gene networks specific to late-onset Alzheimer’s disease. J. Alzheimers Dis. 44, 977–987 (2015).
pubmed: 25380588
Cummings, A. C. et al. Genome-wide association and linkage study in the Amish detects a novel candidate late-onset Alzheimer disease gene. Ann. Hum. Genet 76, 342–351 (2012).
pubmed: 22881374 pmcid: 3419486
Goes, F. S. et al. Genome-wide association study of schizophrenia in Ashkenazi Jews. Am. J. Med. Genet. B Neuropsychiatr. Genet. 168, 649–659 (2015).
pubmed: 26198764
Aliseychik, M. P., Andreeva, T. V. & Rogaev, E. I. Immunogenetic factors of neurodegenerative diseases: the role of HLA class II. Biochemistry 83, 1104–1116 (2018).
pubmed: 30472949
Vazquez-Higuera, J. L. et al. Genetic variation in the tau kinases pathway may modify the risk and age at onset of Alzheimer’s disease. J. Alzheimers Dis. 27, 291–297 (2011).
pubmed: 21811019
Robinson, G., Shallice, T., Bozzali, M. & Cipolotti, L. The differing roles of the frontal cortex in fluency tests. Brain 135(Pt 7), 2202–2214 (2012).
pubmed: 22669082 pmcid: 3381725
Zerbino, D. R., Wilder, S. P., Johnson, N., Juettemann, T. & Flicek, P. R. The ensembl regulatory build. Genome Biol. 16, 56 (2015).
pubmed: 25887522 pmcid: 4407537
Sams, D. S. et al. Neuronal CTCF is necessary for basal and experience-dependent gene regulation, memory formation, and genomic structure of BDNF and Arc. Cell Rep. 17, 2418–2430 (2016).
pubmed: 27880914
Gallagher, M. D. et al. A dementia-associated risk variant near TMEM106B alters chromatin architecture and gene expression. Am. J. Hum. Genet 101, 643–663 (2017).
pubmed: 29056226 pmcid: 5673619
Nakanishi, K. et al. Identification of neurite outgrowth-promoting domains of neuroglycan C, a brain-specific chondroitin sulfate proteoglycan, and involvement of phosphatidylinositol 3-kinase and protein kinase C signaling pathways in neuritogenesis. J. Biol. Chem. 281, 24970–24978 (2006).
pubmed: 16803884
So, H. C. et al. Identification of neuroglycan C and interacting partners as potential susceptibility genes for schizophrenia in a Southern Chinese population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B, 103–113 (2010).
pubmed: 19367581
Zhang, C. et al. The X-linked intellectual disability protein PHF6 associates with the PAF1 complex and regulates neuronal migration in the mammalian brain. Neuron 78, 986–993 (2013).
pubmed: 23791194 pmcid: 3694281
Saito, A. et al. Behavioral abnormalities of fetal growth retardation model rats with reduced amounts of brain proteoglycans. Exp. Neurol. 219, 81–92 (2009).
pubmed: 19393646
Bi, X. et al. Genome-wide mediation analysis of psychiatric and cognitive traits through imaging phenotypes. Hum. Brain Mapp. 38, 4088–4097 (2017).
pubmed: 28544218 pmcid: 5568842
Carrillo-Jimenez, A. et al. TET2 regulates the neuroinflammatory response in microglia. Cell Rep. 29, 697–713 e698 (2019).
pubmed: 31618637
Cochran, J. N. et al. Non-coding and loss-of-function coding variants in TET2 are associated with multiple neurodegenerative diseases. Am. J. Hum. Genet. 106, 632–645 (2020).
pubmed: 32330418 pmcid: 7212268

Auteurs

Xueqiu Jian (X)

Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.

Tamar Sofer (T)

Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Wassim Tarraf (W)

Institute of Gerontology and Department of Health Care Sciences, Wayne State University, Detroit, MI, USA.

Jan Bressler (J)

Department of Epidemiology, Human Genetics and Environmental Sciences and Human Genetics Center, The University of Texas Health Science Center at Houston School of Public Health, Houston, TX, USA.

Jessica D Faul (JD)

Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA.

Wei Zhao (W)

Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.

Scott M Ratliff (SM)

Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.

Melissa Lamar (M)

Department of Behavioral Sciences, Rush Medical College, Chicago, IL, USA.

Lenore J Launer (LJ)

Laboratory of Epidemiology and Population Science, National Institute on Aging, Bethesda, MD, USA.

Cathy C Laurie (CC)

Department of Biostatistics, University of Washington School of Public Health, Seattle, WA, USA.

Neil Schneiderman (N)

Department of Psychology, University of Miami, Coral Gables, FL, USA.

David R Weir (DR)

Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA.

Clinton B Wright (CB)

Division of Clinical Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.

Kristine Yaffe (K)

Department of Psychiatry, University of California, San Francisco, San Francisco, CA, USA.

Donglin Zeng (D)

Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.

Charles DeCarli (C)

Department of Neurology, School of Medicine and Imaging of Dementia and Aging Laboratory, Center for Neuroscience, University of California, Davis, Sacramento, CA, USA.

Thomas H Mosley (TH)

Memory Impairment and Neurodegenerative Dementia (MIND) Center and Department of Medicine, The University of Mississippi Medical Center, Jackson, MS, USA.

Jennifer A Smith (JA)

Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA.
Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.

Hector M González (HM)

Department of Neurosciences and Shiley-Marcos Alzheimer's Disease Research Center, University of California, San Diego, La Jolla, CA, USA.

Myriam Fornage (M)

Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA. Myriam.Fornage@uth.tmc.edu.
Department of Epidemiology, Human Genetics and Environmental Sciences and Human Genetics Center, The University of Texas Health Science Center at Houston School of Public Health, Houston, TX, USA. Myriam.Fornage@uth.tmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH